Royal Bank of Canada’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $13K | Buy |
3,812
+1,006
| +36% | +$3.43K | ﹤0.01% | 6021 |
|
|
2025
Q1 | $11K | Sell |
2,806
-1,261
| -31% | -$4.94K | ﹤0.01% | 5736 |
|
|
2024
Q4 | $25K | Sell |
4,067
-856
| -17% | -$5.26K | ﹤0.01% | 5525 |
|
|
2024
Q3 | $27K | Buy |
4,923
+1,970
| +67% | +$10.8K | ﹤0.01% | 5528 |
|
|
2024
Q2 | $10K | Buy |
2,953
+2,219
| +302% | +$7.51K | ﹤0.01% | 5937 |
|
|
2024
Q1 | $3K | Sell |
734
-10,065
| -93% | -$41.1K | ﹤0.01% | 6131 |
|
|
2023
Q4 | $29K | Buy |
10,799
+5,298
| +96% | +$14.2K | ﹤0.01% | 5656 |
|
|
2023
Q3 | $13K | Buy |
5,501
+1,927
| +54% | +$4.55K | ﹤0.01% | 5834 |
|
|
2023
Q2 | $23K | Buy |
3,574
+1,508
| +73% | +$9.71K | ﹤0.01% | 5680 |
|
|
2023
Q1 | $12K | Sell |
2,066
-1,853
| -47% | -$10.8K | ﹤0.01% | 5841 |
|
|
2022
Q4 | $40K | Buy |
3,919
+3,505
| +847% | +$35.8K | ﹤0.01% | 5539 |
|
|
2022
Q3 | $7K | Buy |
414
+224
| +118% | +$3.79K | ﹤0.01% | 6091 |
|
|
2022
Q2 | $3K | Sell |
190
-1,444
| -88% | -$22.8K | ﹤0.01% | 6352 |
|
|
2022
Q1 | $26K | Sell |
1,634
-4,267
| -72% | -$67.9K | ﹤0.01% | 5976 |
|
|
2021
Q4 | $126K | Buy |
5,901
+4,311
| +271% | +$92.1K | ﹤0.01% | 5235 |
|
|
2021
Q3 | $23K | Buy |
1,590
+668
| +72% | +$9.66K | ﹤0.01% | 6104 |
|
|
2021
Q2 | $18K | Buy |
+922
| New | +$18K | ﹤0.01% | 6111 |
|